Balancing Cancer and Career

The results of a national Harris Interactive survey of working women diagnosed with cancer found that only 1 percent of them viewed their company a source of information or support in handling their illness. Although they are usually satisfied with interpersonal support and report an ability to balance the strain of their illness and their careers, many survey participants reported suffering treatment -connected difficulties on the task, such as fatigue, nausea and hair loss, find little help in workplace programs.
However, many working men and women may find support, information and encouragement in a relative new addition to the support community, Cancer and Career. I first came across them on Twitter, and in spending some time perusing their site, I can whole heartedly offer them as a valuable resource.
Even if you don’t work, this is a content rich site you need to check out. My favorite part? The resource section which includes tons of checklists and charts, including:
• Log of Doctor's Office Visits
• Log of Hospitalizations for Insurance
• Log of Medications for Insurance
• Insurance Claim Chart
• Log of Insurance Phone Calls and Correspondence
• Appointment Log
• Evaluating Treatment Chart
• Illustrated Facial Massage Chart
• Prescription Drug Log
• Make-Up On The Go Guide
For more information, contact http://www.cancerandcareers.org

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap